These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9725413)

  • 1. Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia.
    Kanagasabay RR; Unsworth-White MJ; Robinson G; Bevan D; Farnsworth G; Haxby EJ; Smith EE
    Ann Thorac Surg; 1998 Aug; 66(2):567-9. PubMed ID: 9725413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases.
    Fernandes P; Mayer R; MacDonald JL; Cleland AG; Hay-McKay C
    Perfusion; 2000 Nov; 15(6):531-9. PubMed ID: 11131218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
    Murphy GS; Marymont JH
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):113-26. PubMed ID: 17289495
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
    Kanagasabay R; Unsworth-White MJ; Farnsworth G; Haxby EJ; Smith EE
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):428-9. PubMed ID: 10917979
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s.
    Lubenow N; Warkentin TE; Greinacher A; Wessel A; Sloane DA; Krahn EL; Magnani HN
    Thromb Res; 2006; 117(5):507-15. PubMed ID: 15907979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operations.
    Gitlin SD; Deeb GM; Yann C; Schmaier AH
    J Vasc Surg; 1998 Mar; 27(3):568-75. PubMed ID: 9546248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease.
    Macchi L; Sarfati R; Guicheteau M; Chamlian V; Pourrat O; Gruel Y; Magnin G; Brizard A; Boinot C
    Clin Appl Thromb Hemost; 2000 Oct; 6(4):187-9. PubMed ID: 11030522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifesaving citrate anticoagulation to bridge ineffective danaparoid [correction of to bridge to danaparoid] treatment.
    Dworschak M; Hiesmayr JM; Lassnigg A
    Ann Thorac Surg; 2002 May; 73(5):1626-7. PubMed ID: 12022563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia.
    Aouifi A; Blanc P; Piriou V; Bastien OH; Ffrench P; Hanss M; Lehot JJ
    Ann Thorac Surg; 2001 Feb; 71(2):678-83. PubMed ID: 11235727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
    Olin DA; Urdaneta F; Lobato EB
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients.
    Lindhoff-Last E; Betz C; Bauersachs R
    Clin Appl Thromb Hemost; 2001 Oct; 7(4):300-4. PubMed ID: 11697713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium.
    Grocott HP; Root J; Berkowitz SD; deBruijn N; Landolfo K
    J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):875-7. PubMed ID: 9412888
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary artery bypass grafting in a patient with type II heparin associated thrombopenia.
    Christiansen S; Geiger A; Splittgerber FH; Reidemeister JC
    Cardiovasc Surg; 1998 Feb; 6(1):90-3. PubMed ID: 9546852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
    Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia.
    Gillis S; Merin G; Zahger D; Deeb M; Drenger B; Hyam E; Eldor A
    Br J Haematol; 1997 Sep; 98(3):657-9. PubMed ID: 9332322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin and organon 10172: a successful combination for coronary artery bypass surgery complicated by heparin-induced thrombocytopenia.
    Alvarez MJ; Mezzatesta PJ
    Aust N Z J Surg; 2000 Nov; 70(11):819-21. PubMed ID: 11147447
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of danaparoid anticoagulation for cardiopulmonary bypass.
    Ariano RE; Bhattacharya SK; Moon M; Brownell LG
    J Thorac Cardiovasc Surg; 2000 Jan; 119(1):167-8. PubMed ID: 10612777
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative review of the adverse effect profiles of heparins and heparinoids.
    Borris LC; Lassen MR
    Drug Saf; 1995 Jan; 12(1):26-31. PubMed ID: 7537967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of danaparoid in two pregnant women with heart valve prosthesis and heparin-induced thrombocytopenia Type II (HIT).
    Gerhardt A; Scharf RE; Zotz RB
    Clin Appl Thromb Hemost; 2009; 15(4):461-4. PubMed ID: 18840630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.
    Chong BH; Gallus AS; Cade JF; Magnani H; Manoharan A; Oldmeadow M; Arthur C; Rickard K; Gallo J; Lloyd J; Seshadri P; Chesterman CN;
    Thromb Haemost; 2001 Nov; 86(5):1170-5. PubMed ID: 11816702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.